Ikaria Advancing Critical Care


As a fully intergrated critical care biopharmaceutical company, Ikaria is uniquely positioned to discover, develop, and bring to market unique products that meet the needs of critically ill patients.


Advancing Newborn Medicine Click to Learn More

 

Ikaria Press Releases

July 21, 2008
IKARIA’S INOFLO (NITRIC OXIDE) FOR INHALATION APPROVED IN JAPAN
Ikaria Press Release Read More


May 19 , 2008
IKARIA COMPLETES DOSING OF PHASE 1A CLINICAL STUDY FOR IK-1001 (SODIUM SULFIDE) FOR INJECTION
Ikaria Press Release Read More